Malaria

President Donald Trump gestures as he leaves a meeting with restaurant industry executives about the coronavirus response, in the State Dining Room of the White House, Monday, May 18, 2020, in Washington. (AP Photo/Evan Vucci)
May 18, 2020 - 10:27 pm
NEW YORK (AP) — Fox News Channel anchor Neil Cavuto strongly urged viewers on Monday not to follow the example of President Donald Trump, who revealed that he is taking a malaria drug to protect against the coronavirus. Trump said he has been taking the drug hydroxychloroquine for about a week and...
Read More
Veterans Affairs Secretary Robert Wilkie speaks about protecting seniors, in the East Room of the White House, Thursday, April 30, 2020, in Washington. (AP Photo/Alex Brandon)
May 16, 2020 - 12:14 am
WASHINGTON (AP) — Facing growing criticism, the Department of Veterans Affairs said Friday that it will not halt use of an unproven malaria drug on veterans with COVID-19 but that fewer of its patients are now taking it. In responses provided to Congress and obtained by The Associated Press, the VA...
Read More
Veterans Affairs Secretary Robert Wilkie talks before President Donald Trump arrives to speak about protecting seniors, in the East Room of the White House, Thursday, April 30, 2020, in Washington. (AP Photo/Alex Brandon)
May 10, 2020 - 3:09 pm
WASHINGTON (AP) — The Senate’s top Democrat on Sunday called on the Department of Veterans Affairs to explain why it allowed the use of an unproven drug on veterans for the coronavirus, saying patients may have been put at unnecessary risk. Sen. Charles Schumer of New York said the VA needs to...
Read More
In this image provided by Public Health Emergency, a department of Health and Human Services, Rick Bright is shown in his official photo from April 27, 2017, in Washington. Bright filed a complaint May 5, 2020, with the Office of Special Counsel, a government agency responsible for whistleblower complaints. He’s the former director of the Biomedical Advanced Research and Development Authority. Bright alleges he was removed from his job and reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug favored by President Donald Trump. (Health and Human Services via AP)
AP News
May 09, 2020 - 12:26 am
WASHINGTON (AP) — Federal investigators have found “reasonable grounds” that a government whistleblower was punished for speaking out against widespread use of an unproven drug that President Donald Trump touted as a remedy for COVID-19, his lawyers said. Dr. Rick Bright headed the Biomedical...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine tablets in Las Vegas. According to results released on Thursday, May 7, 2020, a new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection. Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 consecutive patients treated at Columbia University Irving Medical Center in New York. (AP Photo/John Locher)
May 07, 2020 - 5:17 pm
A new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection. Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 patients treated at Columbia University in New York,...
Read More
In this image provided by Public Health Emergency, a department of Health and Human Services, Rick Bright is shown in his official photo from April 27, 2017, in Washington. Bright filed a complaint May 5, 2020, with the Office of Special Counsel, a government agency responsible for whistleblower complaints. He’s the former director of the Biomedical Advanced Research and Development Authority. Bright alleges he was removed from his job and reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug favored by President Donald Trump. (Health and Human Services via AP)
AP News
May 06, 2020 - 12:13 am
WASHINGTON (AP) — The Trump administration failed to prepare for the onslaught of the coronavirus, then sought a quick fix by trying to rush an unproven drug to patients, a senior government scientist alleged in a whistleblower complaint. Dr. Rick Bright, former director of the Biomedical Advanced...
Read More
In this image provided by Public Health Emergency, a department of Health and Human Services, Rick Bright is shown in his official photo from April 27, 2017, in Washington. Bright filed a complaint May 5, 2020, with the Office of Special Counsel, a government agency responsible for whistleblower complaints. He’s the former director of the Biomedical Advanced Research and Development Authority. Bright alleges he was removed from his job and reassigned to a lesser role because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug favored by President Donald Trump. (Health and Human Services via AP)
May 05, 2020 - 6:25 pm
WASHINGTON (AP) — The Trump administration failed to prepare for the onslaught of the coronavirus, then sought a quick fix by trying to rush an unproven drug to patients, a senior government scientist alleged in a whistleblower complaint Tuesday. Dr. Rick Bright, former director of the Biomedical...
Read More
May 01, 2020 - 4:51 pm
WASHINGTON (AP) — Jerome Corsi, a conservative author and conspiracy theorist who was a target in special counsel Robert Mueller’s investigation, says the Justice Department is now scrutinizing his communications with a doctor who has touted an anti-malaria drug as a treatment for the new...
Read More
FILE - In this April 18, 2020, file photo, children wait to receive free food distributed in a slum during a lockdown to check the spread of the new coronavirus in Mumbai, India. A plan to give the anti-malarial drug hydroxychloroquine to thousands of people in Mumbai’s crowded slums to prevent coronavirus infections has temporarily been shelved, officials said Wednesday, April 29. (AP Photo/Rajanish Kakade, File)
April 29, 2020 - 8:57 pm
NEW DELHI (AP) — A plan to give the anti-malarial drug hydroxychloroquine to thousands of people in Mumbai’s crowded slums to prevent coronavirus infections has temporarily been shelved, officials said Wednesday. Health officials in Mumbai said that a test to prove the efficacy of the much touted...
Read More
Veterans Affairs Secretary Robert Wilkie speaks during a coronavirus task force briefing at the White House, Sunday, April 5, 2020, in Washington. (AP Photo/Patrick Semansky)
April 29, 2020 - 5:37 pm
WASHINGTON (AP) — Veterans Affairs Secretary Robert Wilkie on Wednesday defended the use of an unproven drug on veterans for the coronavirus, insisting they were never used as “test subjects” but given the treatment only when medically appropriate. In a letter and call with major veterans...
Read More

Pages